Novel Drug Delivery System (NDDS) Market To Witness Widespread Expansion During 2026

Novel Drug Delivery System (NDDS) Market to
Reap Excessive Revenues by 2026
Novel Drug Delivery System (NDDS) Market - Global Industry Insights, Trends,
Outlook, and Opportunity Analysis, 2018-2026
Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical
compound in the body, and approaches needed to achieve the desired therapeutic effect. The side
effects and slow processing of conventional drug therapy are contributing to the emergence of novel
drug delivery system’s concept. Novel ideas based on interdisciplinary approaches controlling the
pharmacodynamics, immunogenicity, pharmacokinetics, bio-recognition, and efficiency of drugs were
generated. This new system helps in reducing the drug degradation, increasing availability of drugs,
and prevent from harmful side effects of drugs. This system provides various commercial and
therapeutic benefits by enabling to formulate the novel drug delivery devices so that it can incorporate
the drug molecules into the new delivery system. Click To Read More On Novel Drug Delivery
System (NDDS) Market.

Increasing use of novel drug delivery system in cancer therapy is driving the market
Growing prevalence of chronic diseases, drug innovation, and the rising biologics market is also
contributing to the growth of novel drug delivery systems market. According to data published by
Fraser Institute Canada in July 2016, around 22% of overall sales of pharmaceutical firms in 2013 and
expected to reach 32% by 2023 globally. The global spending on biologics has increased by 7% as
compared to previous year.
Effectiveness of novel drug delivery system in cancer therapy is also a major factor propelling the
novel drug delivery systems market growth. For instance, according to the data published by
International Journal of Pharma Sciences and Research (IJPSR), around 9 million deaths occurred due
to cancer in 2015 and estimations reveal that around 11.4 million people are expected to die due to
cancer by 2030. However, patent cliff, patent expiry, and an increase in injury cases are the factors
hindering the growth of global novel drug delivery systems market.
Key industry players are adopting strategy such as geographical expansion and agreement with
other companies to hold the lead in the novel drug delivery system market
Key industry players operating the novel drug delivery system (NDDS) market include Abbott
Laboratories Limited, Johnson & Johnson, 3M Company, Bayer AG, Novartis AG, Teva
Pharmaceuticals Industries Limited, Boston Scientific, AstraZeneca Plc., Sanofi SA, and Genzyme Co..
The key industry players are involved in applying strategies such as geographical expansion, low-cost
strategy, agreement with other companies, and penetration strategy to hold the largest share in the
highly competitive novel drug delivery systems market. For instance, Vetter Pharmaceutical and
Microdermics Inc. have done strategic corporation agreement recently with each other to develop
innovative micro needle drug delivery system.

The global novel drug delivery system (NDDS) market is segmented by route of administration
type, carrier type, and end user.
On the basis of route of administration type, the novel drug delivery system (NDDS) market is
segmented into
•Injectable
•Oral
•Pulmonary
•Transdermal
•others
On the basis of carrier type, the novel drug delivery system (NDDS) market is segmented into
•Nanoparticles
•Liposomes
•Microspheres
•Monoclonal antibodies
•others
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/801
Increase in investment in research and development for new medicines is accounting for the
growth of novel drug delivery systems market in North America
Regional segmentation of novel drug delivery system (NDDS) market by Coherent Market Insights
comprises of North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. North
America holds the major share in the novel drug delivery systems market owing to the factors such as
growing research and development in the field of drug delivery systems, the high adoption rate of new

technology, and supportive reimbursement policies. According to Pharmaceutical Research and
Manufacturers of America (PhRMA), the members of PhRMA have invested an estimated amount of
$51.2 billion in 2014 in research and development of novel medicines. Asia Pacific is also expected to
witness growth in the novel drug delivery systems market due to the increase in investment in
pharmaceutical and biotechnology Industry and growing research and development in the healthcare
sector.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com